Guardant Historical Income Statement

GH Stock

USD 35.40 2.75 8.42%

Historical analysis of Guardant Health income statement accounts such as Interest Income of 37.1 M can show how well Guardant Health performed in making a profits. Evaluating Guardant Health income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Guardant Health's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Guardant Health latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Guardant Health is a good buy for the upcoming year.

Net Income Gross Profit

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

About Guardant Income Statement Analysis

Guardant Health Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Guardant Health shareholders. The income statement also shows Guardant investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Guardant Health Income Statement Chart

As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit Income Before Tax

Total Revenue

Total revenue comprises all receipts Guardant Health generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Guardant Health minus its cost of goods sold. It is profit before Guardant Health operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Guardant Health income statement and is an important metric when analyzing Guardant Health profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Guardant Health's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Guardant Health current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Guardant Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.As of now, Guardant Health's Depreciation And Amortization is increasing as compared to previous years. The Guardant Health's current Interest Expense is estimated to increase to about 2.8 M, while Selling General Administrative is projected to decrease to under 118.7 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	22.3M	36.0M	42.9M	45.0M
Interest Income	3.9M	6.1M	35.4M	37.1M

Depreciation And Amortization Interest Income

Guardant Health income statement Correlations

	Tax Provision	Net Interest Income	Interest Income	Depreciation And Amortization	Interest Expense	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Net Income From Continuing Ops	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Minority Interest	Reconciled Depreciation	Non Operating Income Net Other
Tax Provision		0.2	0.24	0.51	0.45	0.44	0.53	0.41	0.39	0.51	-0.62	-0.65	-0.64	0.56	-0.65	0.49	0.52	-0.65	-0.06	-0.65	1.0	-0.67	0.49	-0.6
Net Interest Income	0.2		1.0	0.86	-0.17	0.5	0.61	0.69	0.66	0.64	-0.73	-0.61	-0.62	0.76	-0.6	0.89	0.62	-0.61	0.68	-0.61	0.2	-0.46	0.7	-0.73
Interest Income	0.24	1.0		0.86	-0.11	0.51	0.61	0.69	0.66	0.65	-0.74	-0.62	-0.62	0.77	-0.6	0.89	0.63	-0.62	0.69	-0.62	0.24	-0.48	0.71	-0.73
Depreciation And Amortization	0.51	0.86	0.86		-0.07	0.77	0.9	0.9	0.89	0.9	-0.97	-0.93	-0.93	0.98	-0.92	0.99	0.89	-0.93	0.33	-0.93	0.51	-0.82	0.92	-0.87
Interest Expense	0.45	-0.17	-0.11	-0.07		0.17	-0.09	-0.06	-0.05	-0.02	-0.02	-0.03	-0.01	-0.04	-0.01	-0.05	-0.01	-0.02	-0.01	-0.03	0.45	-0.18	-0.07	0.07
Selling General Administrative	0.44	0.5	0.51	0.77	0.17		0.84	0.9	0.93	0.9	-0.85	-0.84	-0.84	0.84	-0.85	0.77	0.91	-0.84	0.13	-0.84	0.44	-0.92	0.81	-0.45
Selling And Marketing Expenses	0.53	0.61	0.61	0.9	-0.09	0.84		0.97	0.96	0.99	-0.94	-0.96	-0.96	0.94	-0.96	0.87	0.99	-0.96	0.04	-0.96	0.53	-0.89	0.99	-0.79
Total Revenue	0.41	0.69	0.69	0.9	-0.06	0.9	0.97		1.0	0.99	-0.93	-0.91	-0.92	0.93	-0.91	0.89	0.99	-0.91	0.19	-0.91	0.41	-0.87	0.98	-0.7
Gross Profit	0.39	0.66	0.66	0.89	-0.05	0.93	0.96	1.0		0.99	-0.92	-0.91	-0.92	0.92	-0.91	0.88	0.99	-0.91	0.16	-0.91	0.39	-0.88	0.96	-0.67
Other Operating Expenses	0.51	0.64	0.65	0.9	-0.02	0.9	0.99	0.99	0.99		-0.95	-0.94	-0.95	0.94	-0.94	0.88	1.0	-0.94	0.13	-0.94	0.51	-0.9	0.98	-0.73
Operating Income	-0.62	-0.73	-0.74	-0.97	-0.02	-0.85	-0.94	-0.93	-0.92	-0.95		0.98	0.98	-0.99	0.97	-0.96	-0.95	0.98	-0.23	0.98	-0.62	0.93	-0.94	0.82
Net Income From Continuing Ops	-0.65	-0.61	-0.62	-0.93	-0.03	-0.84	-0.96	-0.91	-0.91	-0.94	0.98		1.0	-0.97	1.0	-0.9	-0.95	1.0	-0.02	1.0	-0.65	0.94	-0.93	0.83
Ebit	-0.64	-0.62	-0.62	-0.93	-0.01	-0.84	-0.96	-0.92	-0.92	-0.95	0.98	1.0		-0.97	1.0	-0.9	-0.95	1.0	-0.03	1.0	-0.64	0.94	-0.94	0.83
Research Development	0.56	0.76	0.77	0.98	-0.04	0.84	0.94	0.93	0.92	0.94	-0.99	-0.97	-0.97		-0.97	0.97	0.94	-0.97	0.23	-0.97	0.56	-0.9	0.94	-0.83
Ebitda	-0.65	-0.6	-0.6	-0.92	-0.01	-0.85	-0.96	-0.91	-0.91	-0.94	0.97	1.0	1.0	-0.97		-0.89	-0.95	1.0	0.0	1.0	-0.65	0.94	-0.93	0.82
Cost Of Revenue	0.49	0.89	0.89	0.99	-0.05	0.77	0.87	0.89	0.88	0.88	-0.96	-0.9	-0.9	0.97	-0.89		0.88	-0.9	0.43	-0.9	0.49	-0.81	0.9	-0.83
Total Operating Expenses	0.52	0.62	0.63	0.89	-0.01	0.91	0.99	0.99	0.99	1.0	-0.95	-0.95	-0.95	0.94	-0.95	0.88		-0.95	0.11	-0.95	0.52	-0.92	0.98	-0.72
Income Before Tax	-0.65	-0.61	-0.62	-0.93	-0.02	-0.84	-0.96	-0.91	-0.91	-0.94	0.98	1.0	1.0	-0.97	1.0	-0.9	-0.95		-0.02	1.0	-0.65	0.94	-0.93	0.83
Total Other Income Expense Net	-0.06	0.68	0.69	0.33	-0.01	0.13	0.04	0.19	0.16	0.13	-0.23	-0.02	-0.03	0.23	0.0	0.43	0.11	-0.02		-0.02	-0.06	-0.06	0.15	-0.09
Net Income	-0.65	-0.61	-0.62	-0.93	-0.03	-0.84	-0.96	-0.91	-0.91	-0.94	0.98	1.0	1.0	-0.97	1.0	-0.9	-0.95	1.0	-0.02		-0.65	0.94	-0.93	0.83
Income Tax Expense	1.0	0.2	0.24	0.51	0.45	0.44	0.53	0.41	0.39	0.51	-0.62	-0.65	-0.64	0.56	-0.65	0.49	0.52	-0.65	-0.06	-0.65		-0.67	0.49	-0.6
Minority Interest	-0.67	-0.46	-0.48	-0.82	-0.18	-0.92	-0.89	-0.87	-0.88	-0.9	0.93	0.94	0.94	-0.9	0.94	-0.81	-0.92	0.94	-0.06	0.94	-0.67		-0.84	0.61
Reconciled Depreciation	0.49	0.7	0.71	0.92	-0.07	0.81	0.99	0.98	0.96	0.98	-0.94	-0.93	-0.94	0.94	-0.93	0.9	0.98	-0.93	0.15	-0.93	0.49	-0.84		-0.82
Non Operating Income Net Other	-0.6	-0.73	-0.73	-0.87	0.07	-0.45	-0.79	-0.7	-0.67	-0.73	0.82	0.83	0.83	-0.83	0.82	-0.83	-0.72	0.83	-0.09	0.83	-0.6	0.61	-0.82

Click cells to compare fundamentals

Guardant Health Account Relationship Matchups

Guardant Health income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Tax Provision	(1.9M)	379K	300K	1.1M	685K	719.3K
Net Interest Income	12.6M	5.4M	1.4M	3.5M	32.8M	34.4M
Interest Income	13.7M	10.2M	3.9M	6.1M	35.4M	37.1M
Depreciation And Amortization	13.8M	16.1M	22.3M	36.0M	42.9M	45.0M
Interest Expense	1.3M	1.2M	4.8M	2.6M	2.6M	2.8M
Selling General Administrative	61.4M	192.8M	206.6M	164.0M	155.8M	118.7M
Selling And Marketing Expenses	78.3M	106.5M	191.9M	299.8M	295.2M	149.0M
Total Revenue	214.4M	286.7M	373.7M	449.5M	563.9M	282.4M
Gross Profit	143.7M	194.2M	250.7M	293.2M	336.9M	177.0M
Other Operating Expenses	296.7M	541.7M	784.7M	993.9M	1.1B	567.2M
Operating Income	(82.4M)	(255.0M)	(411.0M)	(544.4M)	(564.7M)	(536.5M)
Net Income From Continuing Ops	(67.9M)	(246.3M)	(384.8M)	(654.6M)	(479.4M)	(455.5M)
Ebit	(82.4M)	(241.1M)	(381.9M)	(650.9M)	(476.2M)	(452.4M)
Research Development	86.3M	149.9M	263.2M	373.8M	367.2M	385.6M
Ebitda	(68.5M)	(225.1M)	(359.6M)	(614.9M)	(433.3M)	(411.6M)
Cost Of Revenue	70.7M	92.5M	122.9M	156.3M	227.1M	238.4M
Total Operating Expenses	226.0M	449.1M	661.7M	837.6M	901.6M	461.8M
Income Before Tax	(69.7M)	(245.9M)	(384.5M)	(653.4M)	(478.8M)	(454.8M)
Total Other Income Expense Net	12.6M	9.0M	26.5M	(109.1M)	86.0M	90.3M
Net Income Applicable To Common Shares	(75.7M)	(253.8M)	(405.7M)	(654.6M)	(589.1M)	(559.7M)
Net Income	(67.9M)	(246.3M)	(384.8M)	(654.6M)	(479.4M)	(455.5M)
Income Tax Expense	(1.9M)	379K	300K	1.1M	685K	719.3K
Reconciled Depreciation	13.6M	16.1M	22.3M	36.0M	42.9M	22.5M
Non Operating Income Net Other	13.8M	13.8M	29.1M	(106.5M)	(95.8M)	(91.1M)

Currently Active Assets on Macroaxis

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America
S	SentinelOne
WD	Walker Dunlop

How To Invest In Guardant

Details

Is Guardant Stock a good investment?

Details

What is Guardant Health's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

For more detail on how to invest in Guardant Stock please use our How to Invest in Guardant Health guide.

You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Guardant Health. If investors know Guardant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Guardant Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(4.28)

Revenue Per Share

5.7

Quarterly Revenue Growth

0.339

Return On Assets

(0.16)

Return On Equity

(6.09)

The market value of Guardant Health is measured differently than its book value, which is the value of Guardant that is recorded on the company's balance sheet. Investors also form their own opinion of Guardant Health's value that differs from its market value or its book value, called intrinsic value, which is Guardant Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Guardant Health's market value can be influenced by many factors that don't directly affect Guardant Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Guardant Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Guardant Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Guardant Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Guardant Historical Income Statement

About Guardant Income Statement Analysis

Guardant Health Income Statement Chart

Total Revenue

Gross Profit

Income Before Tax

Guardant Health income statement Correlations

Guardant Health Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Guardant Health income statement Accounts

Currently Active Assets on Macroaxis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Income Tax Expense	+ 1.0	Tax Provision
Interest Income	+ 1.0	Net Interest Income
Gross Profit	+ 1.0	Total Revenue
Total Operating Expenses	+ 1.0	Other Operating Expenses
Ebit	+ 1.0	Net Income From Continuing Ops
Ebitda	+ 1.0	Net Income From Continuing Ops

Research Development	- 0.99	Operating Income
Net Income	- 0.97	Research Development
Income Before Tax	- 0.97	Research Development
Ebitda	- 0.97	Research Development
Research Development	- 0.97	Ebit
Research Development	- 0.97	Net Income From Continuing Ops